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Objective: To identify alterations in the cytokine profile and microbial ecosystem of the vagina in association
with cervical dysplasia.
Methods: Demographics, lifestyle variables and Papanicolau (Pap) smear results of subjects presenting to the
same site for gynecologic complaints, obstetric visits or colposcopy were prospectively recorded. Vaginal smear
forGramstain,aerobicandanaerobicculture,pH,andwetmountandKOHexamination forTrichomonas vaginalis,
Gardnerella vaginalis and yeast organisms were performed. Vaginal lavage specimens were centrifuged, and the
pellets and supernatants were assayed for human papillomavirus (HPV) by polymerase chain reaction and for
cytokines interleukin (IL)-1b IL-6, IL-10 and IL-12 by enzyme-linked immunosorbent assay (ELISA) respectively.
Subjects with abnormal Pap smears underwent colposcopy and biopsy as indicated.
Results: Of 51 patients, 32 were referred for colposcopy, 12 presented with gynecologic needs, and seven
presented for obstetric visits. Median age was 24 years. Demographics did not differ significantly between the
dysplasiaandcontrolgroupsexceptfora trendtowardsmoresexualpartnersinthedysplasiagroup.Biopsieswere
performed in 81% (26/32) of patients presentingfor colposcopy and 17 revealed cervical intraepithelial neoplasia.
IL-1b, IL-6, IL-10, and IL-12 levels were elevated in 63% (20/32), 38% (15/39), 4% (2/49), and 0% of samples
respectively.Elevated vaginal lavage IL-1b was associated with a 6.1 odds ratio (95% confidence interval 1.06–35)
of cervical dysplasia. Alterations in other variables studied were not associated with cervical dysplasia.
Conclusions: ElevatedIL-1b,possiblyrepresentinga complex host inflammatory responseto multiple pathogens,
was demonstrated in patients with cervical dysplasia.
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INTRODUCTION
Neoplasms of theuterinecervix are a publichealth
problem. In the United States, women affected
annually include 2.5 million with cervical
dysplasia, 50 000 with cervical carcinoma in situ
and 16 000with cervical carcinoma1,2. While early
detection may decrease advanced disease, altering
exposurewill reduce theoccurrenceof disease and
is a preferred strategy.
Some studies show a higher incidence of
dysplasia in women with bacterial vaginosis
(BV)3,4. Alternatively, the presence of inflamma-
tory cytokines related to alterations in the vaginal
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Clinical study 181environment, and not the presence of the patho-
gens themselves, might play a role as a promoting
factor5. In supportof this, increased levels of IL-1b
were seen in the cervical mucus of pregnant
patients with BV. Furthermore, cervical mucus
fromthesewomenwithBVinducedproductionof
IL-6 from monocytic cells in vitro6. In another
study, a shift to TH2 cytokines (IL-4, IL-10) was
observed with increasing grades of cervical
dysplasia7. Therefore, changes in the microbial
flora, cytokine profile, or both may predispose to
cervical dysplasia.
As an alternative to cervical mucus assays,
cytokine concentrations in the vaginal environ-
ment can be evaluated using vaginal lavage. Using
this technique, Sha and co-workers demonstrated
increased IL-1b levels in HIV-infected patients
with cervical dysplasia compared with HIV-
infected patients without cervical dyspalsia8. In
this study, we prospectively evaluated the clinical
presentation, presence of infection, and cytokine
profile, via vaginal lavage, of patients with and
without cervical dysplasia.
MATERIALS AND METHODS
The study population included all patients aged
13–65 years presenting to outpatient facilities at
Rush-Presbyterian-St. Luke’s Medical Center
between January and October 2000. Participants
signed an Institutional Review Board (IRB)-
approved consent specifically for this study.
Patients included those with abnormal Pap smears
presenting for colposcopy to the study authors
and additional patients presenting to the same
site for routine gynecologic or obstetric care.
The sample group consisted of patients with
biopsy-proven dysplasia, and the control group
consisted of those with normal Pap smear, normal
biopsies or a colposcopic examination that ruled
out a high-grade lesion.
Initial visits consistedofstudyexplanation,sign-
ing of the consent form and addressing the reason
for the visit. Information was then collected
including: age, parity, age at first intercourse,
smoking history, history of sexually transmitted
diseases, and number of sexual partners. Cervical
and vaginal specimens for vaginal pH, wet mount
for the presence of Trichomonas vaginalis, KOH
prep for the presence of yeast, Gram stain with
evaluation of altered vaginal flora using Nugent’s
criteria9, and aerobic and anaerobic cultures were
obtained. Subsequently, the cervix and vagina
were lavaged with 5 cm3 of sterile saline and
specimens centrifuged to yield supernatants for
cytokine profile assays and pellets for human
papillomavirus (HPV) determination. Interleukin
(IL)-1b, IL-6, IL-10, and IL-12 levels were
assayed by enzyme-linked immunosorbent assay
(ELISA) (R&D systems, Minneapolis, MN). HPV
was assayed by polymerase chain reaction (PCR)
using L1 consensus primers (5¢-TTT GTT ACT
GTG GTA GAT AC-3¢, 5¢-GAA AAA TAA
ACT GTA AAT CA-3¢; annealing temperature,
45°C).
Lactobacilli from vaginal specimens were iso-
lated by inoculating MRS agar (Remel, Lenexa,
KS), incubated anaerobically at 36°C for 24–48
hours. Gardnerella vaginalis was isolated by
inoculating the vaginal specimens on human-
blood-bilayer tween (HBT) agar (Becton
Dickinson, Baltimore, MA) and incubating in 5%
CO2 atmosphere at 37°C for 48 hours. Sabouraud
agar (Hardy Diagnostics, Santa Monica, CA) was
used forisolation ofyeast. Trichomonasvaginaliswas
isolated by inoculating the vaginal specimens on
Diamond media (Queleb, Montreal, Canada) and
incubating at 37°C for 7 days.
All of the wet mount, KOH prep and vaginal
pH assessments were analyzed by one of two
investigators using standard methodology10. One
investigator performed all the colposcopies and
biopsies. Pap smear reports were reviewed, but
slides werenotreviewedagain byacytopathologist
specifically for this study.
SPSS Version 11 for Windows(SPSS, Chicago,
IL) was used for data management and statistical
analysis. Groups were compared with respect to
categorical variables using the chi-square test of
association or Fisher’s exact test, and with respect
to non-categorical, statistically non-normal
variables using the Mann–Whitney U-test. A 0.05
significance level was used for all statistical tests.
RESULTS
Of 51 patients included in the study, 32 were
referred to a colposcopy clinic, 12 presented with
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obstetric visits. Overall, 18 pregnant women were
admitted to the study including those presenting
for colposcopy. Approximately 78% (40) and
15.7% (eight) of the patients were African-
American and Hispanic respectively. Seventeen
patients (33%) with biopsy-proven dysplasia were
the sample patients; 34 (67%) with normal biop-
sies or a colposcopic exam that ruled out dysplasia
were the control patients.
Studygroupsdid notdiffer significantly in con-
tinuous variables (Table 1) such as age, age at first
intercourse, tobacco use and parity. There was a
trend towards more sexual partnersin thedysplasia
group (p = 0.08 by chi-square). Groups also did
not differ significantly in categorical variables
(Table 2) such as history of sexually transmitted
disease (STD), presence of BV by clinical criteria11
or Gram stain or culture, presence of HPV, or
elevated vaginal fluid IL-6 (greater than 2 pg/ml).
Vaginal IL-1b concentration was significantly
elevated in 11/13 (85%) of dysplasia patients com-
pared with 9/19 (47%) of controls (p = 0.03 by
chi-square). Odds ratio (OR) for cervical dysplasia
was 6.1 (95% confidence interval (CI) 1.06–35) in
patients with elevated IL-1b. Mean IL-1b was
45 pg/ml (range 0–125 pg/ml) in the no dysplasia
group and 89 pg/ml (range 8–358 pg/ml) in the
dysplasia group.Elevated vaginal IL-1b was corre-
lated witha highernumberofprevioussexualpart-
ners (mean of two partners for normal vaginal
IL-1bvs. mean ofseven forelevated vaginalIL-1b,
p = 0.009, Mann–Whitney U-test). Elevated
IL-1b was not correlated with the presence of
BV by Gram stain. IL-12 was not elevated in any
specimen and IL-10 was present in two specimens,
one contaminated with menstrual blood.
Four of the patients studied had data collected
on two separate visits. Of interest, two of
these patients had elevated IL-6 found on the
return visit only. One patient had a biopsy-proven
herpetic outbreak on the follow-up visit alone
(IL-6 = 300 pg/ml), and the other was menstruat-
ing at the follow-up visit (IL-6 = 75 pg/ml).
Finally,HPVwasdetectedin3/9(33%)patients
with biopsy-proven high-grade lesions compared
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Variable
Dysplasia group, mean ± standard
deviation (n = 17)
No dysplasia group,
mean ± standard deviation (n = 34) Significance
Age
Age at first intercourse



















Table 1 Comparison of continuous variables between dysplasia and no dysplasia groups





Elevated IL-6 concentration > 2 pg/ml*



















*Data were not available for all patients.  Numbers exclude two patients with extremely high values, one with active HSV infection and
another with specimen contaminated with menstrual blood; **data were not available for all patients.  Numbers exclude two patients with
extremely high values, both contaminated with menstrual blood; STD, any episode of pelvic inflammatory disease, chlamydia, or Gonorrhea
cervicitis; BV, bacterial vaginosis; HPV, Human Papillomavirus; NS, not significant
Table 2 Comparison of categorical variables between dysplasia and no dysplasia groupswith 2/32 (6%) patients with low-grade lesions or
no cervical dysplasia (p = 0.06 by Fisher’s exact
test). All specimens testing positive for HPV also
demonstrated elevated IL-1b (mean 35 pg/ml,
range 10–60 pg/ml).
DISCUSSION
The presence of HPV in human cervical cells
has been shown to be an initiating factor in the
development of cervical dysplasia12. However,
not all patients harboring HPV develop cervical
dysplasia, indicating the presence of additional
promoting factors. Multiple studies have shown
that patients with BV have a higher incidence of
cervical dysplasia3,4,13.Inonestudy,theproduction
of nitrosamines by the causative organisms of BV
was shown to promote the development of
cervical dysplasia and cervical cancer5. However,
the interactions in the vaginal mircoenvironment
are complex and higher incidence may not be
related to the pathogens themselves, but to alter-
ations in the microenvironment.
Bacterial vaginosis is a polymicrobial syndrome
involving the lower genital tract and is character-
ized by the replacement of lactobacilli-
predominantflora with G. vaginalis, anaerobes and
Mycoplasma hominis. Furthermore, some biotypes
of G. vaginalis are more strongly associated with
clinical BV14. This polymicrobial infection results
in alterations in the vaginal microenvironment
leading in the extreme to clinical presentation of
vaginal itching, a malodorous discharge, a positive
amine ‘whiff’ test and the presence of clue cells on
a wet smear. However, shifts in vaginal flora are
detectable on Gram stain prior to the onset of
clinical symptoms. It is therefore possible that
silent infection may be present in association with
other diseases.
Matzby-Baltzer and co-workers foundelevated
levels of IL-1b in the lower genital tract of
pregnant women with asymptomatic BV6.
Furthermore, cervical mucus from patients with
BV-induced IL-6 secretion from monocytic cells
in vitro. Sjoberg and co-workers showed that
BV-associated endotoxin is responsible for the
production of lipopolysaccharides capable of
inducing an inflammatory response15. In our
study, elevated IL-1b or IL-6 was not associated
with BV. However, elevated IL-1b was associated
with a higher number of previous sexual partners,
itself a risk factor for bacterial vaginal infections,
infection with HPV, and cervical dysplasia. It is
possiblethatendotoxinproductionisrelated tothe
biotype of G. vaginalis and its interaction with
other pathogens in the vaginal environment. We
do not have biotype data for our G. vaginalis
isolates.
Inourstudy,elevated IL-1bwasassociated with
the presence of cervical dysplasia. This is similar
to findings of elevated vaginal lavage IL-1b in
HIV-positive patients with cervical dysplasia8 and
is supported by an association between cervical
dysplasia and a greater percentage of cells geneti-
cally programmed to secrete IL-1b in cervical
biopsies16. IL-1b has been shownto stimulate HIV
replication in vitro by activation of the long termi-
nal repeat promoter region17. We speculate that
increased IL-1b may similarly promote HPV
replication. This is supported by our finding by
PCR of elevated IL-1b in patients with HPV
infection. However, we have no direct evidence
of this relationship in our study.
IL-10 is a pleiotropic cytokine that is thought
to have immunosuppressive effects on the cervical
epithelium. It is not clear why IL-10 was only
elevated in one of our specimens. Mota and co-
workers demonstrated increased IL-10 expression
with progression from normalcervical epithelium,
then low-grade, to high-grade lesions18,19. Their
data, however, were based on immunohisto-
chemical detection of IL-10 in biopsy specimens,
not from vaginal lavage. It is possible that IL-10
may not be detectable in vaginal lavage while
elevated at the tissue level. In relation to changes
in the local environment, presence of the
cytokine in vaginal lavage fluid may be more
important.
IL-6 is also a multifunctional cytokine, but is
thought to promote an inflammatory response in
the cervical epithelium. Levels of vaginal lavage
IL-6 were < 2 pg/ml in controls, < 2–73 pg/ml,
mean 22 pg/ml in patients with cervical dysplasia
and 54–780 pg/ml, mean 171 pg/ml in patients
with cervical cancer in one study20. Our study
did not include patients with cervical cancer.
Although the mean IL-6 level in our patients
with dysplasia (18 pg/ml, range 0–75 pg/ml) was
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pg/ml), this difference was not significant.
Biases in our study population require discus-
sion. The predominance of African-American
and Hispanic patients in our study reflects
demographics of an urban practice. These results
may not be applicable to patients in alternate
demographic settings. The median age of 22
years in our study and control population was
below that expected for cervical dysplasia and it is
conceivable that some of these women are at
high risk for future development of cervical
dysplasia. It is possible that continued exposure,
not a one-time event, might be the risk factor for
eventual development of dysplasia. For example,
patients with elevated IL-1b without cervical
dysplasia may be at risk for development of
cervical dysplasia in the future.
A disadvantage of the vaginal lavage procedure
is that dilution of cervical secretions is not known
with absolute confidence. While data exist on
conversions from volume-standardized vaginal
lavage levels to cervical mucus levels21, we chose
to report our results as the categorical variable
(elevated or not elevated) rather than the con-
tinuous variable (cytokine level). We report the
cytokinelevels forreferencetoexistingliterature.
We also recognizethe5/39(13%)prevalenceof
HPV in our study is below that expected for this
population. This may be related to our method of
assaying HPV from cells shed in the vaginal lavage.
It is possible that one-time assay of HPV may
miss many patients that carry HPV but are not
actively shedding virus. However, all patients
demonstrating HPV virus in vaginal lavage speci-
mens also exhibited elevated IL-1b, suggesting a
relationship between the presence of virus in the
vaginal environment and the presence of this
cytokine.
Elevated IL-1b is associated with cervical
dysplasia, but not with Gram stain presence of
BV. Presence of HPV in vaginal fluid may be
related to secretion ofIL-1b. Thecause ofelevated
IL-1b is unclear but may be related to multiple
factors resulting in an altered vaginal micro-
environment. Identification of these factors and
their alleviation may help reduce the incidence of
cervical dysplasia.
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